本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ambrx Biopharma Inc

28.00
0.0000
成交量:- -
成交額:4,029.64萬
市值:17.74億
市盈率:-117.80
高:28.00
開:28.00
低:28.00
收:28.00
52周最高:28.15
52周最低:5.56
股本:6,335.22萬
流通股本:2,092.93萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.2377
每股收益(LYR):-0.2886
淨資產收益率:-37.23%
總資產收益率:-18.62%
市淨率:7.32
市盈率(LYR):-97.02

資料載入中...

2023/05/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/16

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/04

重要事件披露

8-K - Current report
2023/04/28

SEC問詢函

Form CORRESP - Correspondence
2023/04/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/04/10

重要事件披露

8-K - Current report
2023/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/16

自願退市

25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2023/03/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/13

重要事件披露

8-K - Current report
2023/03/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/03/06

重要事件披露

8-K - Current report
2023/03/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/01

重要事件披露

8-K - Current report
2023/02/27

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/24

重要事件披露

8-K - Current report